188 related articles for article (PubMed ID: 12694330)
1. Possible mechanisms of homocysteine toxicity.
Perna AF; Ingrosso D; Lombardi C; Acanfora F; Satta E; Cesare CM; Violetti E; Romano MM; De Santo NG
Kidney Int Suppl; 2003 May; (84):S137-40. PubMed ID: 12694330
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine in uremia.
Perna AF; Ingrosso D; Lombardi C; Cesare CM; Acantora F; Satta E; De Santo NG
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S123-6. PubMed ID: 12612968
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine and transmethylations in uremia.
Perna AF; Ingrosso D; Castaldo P; Galletti P; De Santo NG
Kidney Int Suppl; 2001 Feb; 78():S230-3. PubMed ID: 11169016
[TBL] [Abstract][Full Text] [Related]
4. Metabolic consequences of hyperhomocysteinemia in uremia.
Perna AF; Ingrosso D; Satta E; Romano M; Cimmino A; Galletti P; Zappia V; De Santo NG
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S85-90. PubMed ID: 11576929
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia and macromolecule modifications in uremic patients.
Perna AF; Capasso R; Lombardi C; Acanfora F; Satta E; Ingrosso D
Clin Chem Lab Med; 2005; 43(10):1032-8. PubMed ID: 16197294
[TBL] [Abstract][Full Text] [Related]
6. [Hyperhomocysteinemia in chronic renal failure.].
Satta E; Perna AF; Lombardi C; Acanfora F; Violetti E; Romano MM; Capasso R; Pisano M; Paduano F; De Santo NG
G Ital Nefrol; 2006; 23(5):480-9. PubMed ID: 17123261
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine metabolism in renal failure.
van Guldener C; Stam F; Stehouwer CD
Kidney Int Suppl; 2001 Feb; 78():S234-7. PubMed ID: 11169017
[TBL] [Abstract][Full Text] [Related]
8. Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients.
Massy ZA; Ceballos I; Chadefaux-Vekemens B; Nguyen-Khoa T; Descamps-Latscha B; Drüeke TB; Jungers P
Kidney Int Suppl; 2001 Feb; 78():S243-5. PubMed ID: 11169019
[TBL] [Abstract][Full Text] [Related]
9. Plasma protein homocysteinylation in uremia.
Perna AF; Acanfora F; Luciano MG; Pulzella P; Capasso R; Satta E; Cinzia L; Pollastro RM; Iannelli S; Ingrosso D; De Santo NG
Clin Chem Lab Med; 2007; 45(12):1678-82. PubMed ID: 17937608
[TBL] [Abstract][Full Text] [Related]
10. Uremic toxins and peritoneal dialysis.
Lameire N; Vanholder R; De Smet R
Kidney Int Suppl; 2001 Feb; 78():S292-7. PubMed ID: 11169029
[TBL] [Abstract][Full Text] [Related]
11. The Sulfur Metabolite Lanthionine: Evidence for a Role as a Novel Uremic Toxin.
Perna AF; Zacchia M; Trepiccione F; Ingrosso D
Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28075397
[TBL] [Abstract][Full Text] [Related]
12. Hyperhomocysteinemia in uremia--a red flag in a disrupted circuit.
Perna AF; Ingrosso D; Violetti E; Luciano MG; Sepe I; Lanza D; Capasso R; Ascione E; Raiola I; Lombardi C; Stenvinkel P; Massy Z; De Santo NG
Semin Dial; 2009; 22(4):351-6. PubMed ID: 19708980
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine metabolism in renal failure.
Perna AF; Ingrosso D; Satta E; Lombardi C; Acanfora F; De Santo NG
Curr Opin Clin Nutr Metab Care; 2004 Jan; 7(1):53-7. PubMed ID: 15090904
[TBL] [Abstract][Full Text] [Related]
14. Hyperhomocysteinemia and cardiovascular disease in uremia: the newest evidence in epidemiology and mechanisms of action.
Perna AF; Acanfora F; Satta E; Lombardi C; Ingrosso D; De Santo NG
Semin Nephrol; 2004 Sep; 24(5):426-30. PubMed ID: 15490404
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine, a new crucial element in the pathogenesis of uremic cardiovascular complications.
Perna AF; Ingrosso D; Castaldo P; De Santo NG; Galletti P; Zappia V
Miner Electrolyte Metab; 1999; 25(1-2):95-9. PubMed ID: 10207268
[TBL] [Abstract][Full Text] [Related]
16. Plasma proteins containing damaged L-isoaspartyl residues are increased in uremia: implications for mechanism.
Perna AF; Castaldo P; De Santo NG; di Carlo E; Cimmino A; Galletti P; Zappia V; Ingrosso D
Kidney Int; 2001 Jun; 59(6):2299-308. PubMed ID: 11380834
[TBL] [Abstract][Full Text] [Related]
17. Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia.
Mezzano D; Pais EO; Aranda E; Panes O; Downey P; Ortiz M; Tagle R; González F; Quiroga T; Caceres MS; Leighton F; Pereira J
Kidney Int; 2001 Nov; 60(5):1844-50. PubMed ID: 11703602
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of homocysteine-induced atherothrombosis.
Lentz SR
J Thromb Haemost; 2005 Aug; 3(8):1646-54. PubMed ID: 16102030
[TBL] [Abstract][Full Text] [Related]
19. Toxic effects of hyperhomocysteinemia in chronic renal failure and in uremia: cardiovascular and metabolic consequences.
Perna AF; Capasso R; Acanfora F; Satta E; Lombardi C; Ingrosso D; Violetti E; Romano MM; De Santo NG
Semin Nephrol; 2006 Jan; 26(1):20-3. PubMed ID: 16412820
[TBL] [Abstract][Full Text] [Related]
20. Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations.
McGregor DO; Dellow WJ; Lever M; George PM; Robson RA; Chambers ST
Kidney Int; 2001 Jun; 59(6):2267-72. PubMed ID: 11380830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
